Dopamine 2020
Dopamine 2020
批准号:
9914493
负责人:
David Sulzer
金额:
$2.0万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-07-01 至 2022-06-30
关键词:
AmericanAttentionAttention deficit hyperactivity disorderAustriaBasic ScienceBiologicalBrainBrain DiseasesChemicalsCitiesClinicalCollaborationsCommunitiesCountryDevelopmentDisciplineDiseaseDopamineDrug AddictionEuropeanFacultyFellowship ProgramFertilizationFinancial SupportFosteringFranceFunctional disorderFundingGoalsHealthIndividualInstitutionInternationalItalyJoint VenturesJournalsLeadershipMolecularNatureNeurotransmittersNew YorkNew York CityObesityOregonParkinson DiseasePhysiologyPlayPopulationPostdoctoral FellowPublishingQuebecResearchResearch PersonnelRoleSchizophreniaScienceScientistSignal TransductionSocietiesSpecialistStructureSwedenSystemTechniquesUnderrepresented MinorityUnited States National Institutes of HealthWomanWorkWritingaddictionbasecareergender minoritygraduate studentinnovationmeetingsnext generationposterssymposiumtransmission processwaiver
中文摘要
项目概要
本申请旨在为将于 5 月在魁北克省蒙特利尔举行的 2020 年多巴胺会议请求支持
2020 年 18-21 日。这一享有盛誉的国际会议是迄今为止最全面、规模最大的一次
类型,大约每四年举办一次,重点研究大脑化学信使
多巴胺,以及与该系统功能障碍相关的多种脑部疾病,即帕金森病
疾病、精神分裂症、毒瘾、注意力缺陷多动障碍(ADHD)和肥胖。
多巴胺 2020 的目的是为不同背景的科学家提供一个互动和交流的论坛
分享他们关于多巴胺研究的最新工作和想法。我们预计这一机会将促进跨界合作
各种基本方法之间的融合并加快发现的步伐。
数千篇关于正常大脑功能和多巴胺能机制的基础科学文章
前面提到的重要疾病已发表在顶级科学和生物学期刊上,并且
这项研究的创新和重点正在加速。快速的发现带来了迫切的需求
为不同学科的研究人员提供一个论坛,包括生理学、发育学、电路学和
多巴胺在多种疾病中发挥重要作用。这次集中会议提供了理想的场地,
在之前的会议上已经开展了许多合作。
在 NIH 的支持下,Dopamine 2020 将在三个重要方面取得实质性进展
目标。目标 1) 通过确定前沿主题,激发与会者之间的新研究和合作
和技术以及适当的科学家作为演讲者和海报展示者。目标 2) 增加性别和
会议领导层中代表性不足的少数群体 (URM) 多样性和计划的多巴胺
会上将介绍学会。目标3)促进和支持下一代的发展
通过为研究生和研究生提供经济和职业支持,在该领域工作的研究人员
博士研究员。这次会议的独特形式及其广泛的方法、技术和
该领域基础和临床方面的定位对于在全球范围内的进一步发展具有不可估量的价值
了解多巴胺功能在健康和疾病中的作用。
英文摘要
PROJECT SUMMARY
This application is to request support for the Dopamine 2020 Meeting to be held in Montréal, Quebec, on May
18-21, 2020. This prestigious international meeting, which is by far the most comprehensive and largest of its
type and is held approximately every four years, is focused on research on the brain chemical messenger
dopamine, and on the multiple brain diseases associated with dysfunction of this system, namely Parkinson’s
disease, schizophrenia, drug addiction, attention deficit and hyperactivity disorder (ADHD) and obesity.
The purpose of Dopamine 2020 is to provide a forum for scientists with diverse backgrounds to interact and
share their latest work and ideas on dopamine research. We anticipate that this opportunity will foster cross-
fertilization among diverse basic approaches and accelerate the pace of discovery.
Many thousands of basic science articles on dopaminergic mechanisms in normal brain function and the
important disorders mentioned previously have been published in top scientific and biological journals, and the
innovation and focus of this research is accelerating. The rapid pace of discovery has created a pressing need
for a forum for investigators across various disciplines, including physiology, development, circuitry, and the
multiple disorders in which dopamine plays an important role. This focused meeting provides an ideal venue,
and many collaborations have developed at previous meetings.
With support through the NIH, Dopamine 2020 will make substantive progress furthering three important
goals. Aim 1) Stimulate new research and collaborations among attendees by identifying cutting-edge topics
and techniques and appropriate scientists as speakers and poster presenters. Aim 2) Increase gender and
underrepresented minority (URM) diversity within the leadership of the meeting and the planned Dopamine
Society to be introduced at the meeting. Aim 3) Promote and support the development of the next generation
of researchers working in this field by providing financial and career support for graduate students and post-
doctoral fellows. The unique format of this meeting, with its wide scope of approaches, techniques, and
orientation towards both basic and clinical aspects in the field is of immeasurable value to furthering worldwide
understanding of the role of dopamine function in health and disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Effects of Cannabis on Neuronal Translation
-
批准号:9035835
-
项目类别:
-
资助金额:$8.0万
-
财政年份:2016
-
负责人:David Sulzer
-
依托单位:
2015 Parkinson's Disease Gordon Research Conference
-
批准号:8835619
-
项目类别:
-
资助金额:$2.0万
-
财政年份:2014
-
负责人:David Sulzer
-
依托单位:
ROLES FOR ALPHA-SYNUCLEIN DEGRADATION AND CYTOSOLIC DOPAMINE IN PD PATHOGENESIS
-
批准号:8411745
-
项目类别:
-
资助金额:$8.4万
-
财政年份:2012
-
负责人:David Sulzer
-
依托单位:
Spectra-Physics Mai Tai HP Laser
-
批准号:7794473
-
项目类别:
-
资助金额:$19.58万
-
财政年份:2010
-
负责人:David Sulzer
-
依托单位:
Presynaptic Plasticity of Vesicular Dopamine Release
-
批准号:7513682
-
项目类别:
-
资助金额:$13.62万
-
财政年份:2007
-
负责人:David Sulzer
-
依托单位:
PRESYNAPTIC PLASTICITY OF VESICULAR DOPAMINE RELEASE
-
批准号:7088089
-
项目类别:
-
资助金额:$16.29万
-
财政年份:2006
-
负责人:David Sulzer
-
依托单位:
2005 Gordon Conference on Catecholamines
-
批准号:6938742
-
项目类别:
-
资助金额:$5.5万
-
财政年份:2005
-
负责人:David Sulzer
-
依托单位:
Basic Neuroscience Training Grant at Columbia University
-
批准号:6749766
-
项目类别:
-
资助金额:$22.64万
-
财政年份:2004
-
负责人:David Sulzer
-
依托单位:
Basic Neuroscience Training Grant at Columbia University
-
批准号:8099760
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2004
-
负责人:David Sulzer
-
依托单位:
Basic Neuroscience Training Grant at Columbia University
-
批准号:7869590
-
项目类别:
-
资助金额:$17.93万
-
财政年份:2004
-
负责人:David Sulzer
-
依托单位:
Altered lysosomal degradation in PD
-
批准号:6812924
-
项目类别:
-
资助金额:$32.94万
-
财政年份:2004
-
负责人:David Sulzer
-
依托单位:
Basic Neuroscience Training Grant at Columbia University
-
批准号:7262404
-
项目类别:
-
资助金额:$44.22万
-
财政年份:2004
-
负责人:David Sulzer
-
依托单位:
Basic Neuroscience Training Grant at Columbia University
-
批准号:7465436
-
项目类别:
-
资助金额:$44.91万
-
财政年份:2004
-
负责人:David Sulzer
-
依托单位:
Basic Neuroscience Training Grant at Columbia University
-
批准号:6950714
-
项目类别:
-
资助金额:$46.01万
-
财政年份:2004
-
负责人:David Sulzer
-
依托单位:
Basic Neuroscience Training Grant at Columbia University
-
批准号:7091648
-
项目类别:
-
资助金额:$40.19万
-
财政年份:2004
-
负责人:David Sulzer
-
依托单位:
Molecular analysis of altered intracellular dopamine pools in substantia nigra
-
批准号:6336723
-
项目类别:
-
资助金额:$22.58万
-
财政年份:2000
-
负责人:David Sulzer
-
依托单位:
PRESYNAPTIC PLASTICITY OF VESICULAR DOPAMINE RELEASE
-
批准号:6201619
-
项目类别:
-
资助金额:$22.22万
-
财政年份:1999
-
负责人:David Sulzer
-
依托单位:
Molecular analysis of altered intracellular dopamine pools in substantia nigra
-
批准号:6259642
-
项目类别:
-
资助金额:$22.58万
-
财政年份:1999
-
负责人:David Sulzer
-
依托单位:
Molecular analysis of altered intracellular dopamine pools in substantia nigra
-
批准号:6302886
-
项目类别:
-
资助金额:$22.58万
-
财政年份:1999
-
负责人:David Sulzer
-
依托单位:
PRESYNAPTIC PLASTICITY OF VESICULAR DOPAMINE RELEASE
-
批准号:6104144
-
项目类别:
-
资助金额:$22.22万
-
财政年份:1998
-
负责人:David Sulzer
-
依托单位:
国内基金
海外基金
多模态超声VisTran-Attention网络评估早期子宫颈癌保留生育功能手术可行性
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:郑巧
-
依托单位:
Ultrasomics-Attention孪生网络早期精准评估肝内胆管癌免疫治疗的研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:陈立达
-
依托单位: